← Ophthalmology
Ophthalmology
Latanoprost eye drops
Prostaglandin-analogue eye drops included in the former ophthalmology portfolio.
Product overview
What it is.
- A prostaglandin analogue for the treatment of glaucoma, a group of eye conditions that damage the optic nerve and are often associated with elevated intraocular pressure (IOP).
- Primary open-angle glaucoma is the most common type (85–90% of cases): a slow, painless drainage blockage with no symptoms until late stages.
- Treatment aims to lower IOP to a target level to halt optic-nerve damage. There is no cure, and vision lost to glaucoma is permanent.
Specifications
Key figures.
Figures are as presented on the former site and are not approved product claims.
- Drug class
- Prostaglandin analogue
- Mechanism
- Increases uveoscleral outflow
- IOP reduction (legacy figure)
- 25–35%
- Dosing (legacy)
- Once daily, in the evening
Portfolio information
From the original portfolio.
Content review draft
The former site presents latanoprost in the management of elevated intraocular pressure and glaucoma. Product-specific formulation and authorization need confirmation.
This page preserves the former site’s product information for review. It does not establish current Canadian availability, approved indications, performance, or prescribing information. Request verified documentation before relying on it.
Request verified informationExplore this area